To date, still little is known about TAS1Rs’ role in mediating SARS-CoV-2 immune response, while a few studies have investigated the relationship between TAS2R38 activity and COVID-19 symptom severity, with variable results. This evidence concerns the gene TAS2R38 and COVID-19.